» Articles » PMID: 33121041

Microneedles: Characteristics, Materials, Production Methods and Commercial Development

Overview
Publisher MDPI
Date 2020 Oct 30
PMID 33121041
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Although transdermal drug delivery systems (DDS) offer numerous benefits for patients, including the avoidance of both gastric irritation and first-pass metabolism effect, as well as improved patient compliance, only a limited number of active pharmaceutical ingredients (APIs) can be delivered accordingly. Microneedles (MNs) represent one of the most promising concepts for effective transdermal drug delivery that penetrate the protective skin barrier in a minimally invasive and painless manner. The first MNs were produced in the 90s, and since then, this field has been continually evolving. Therefore, different manufacturing methods, not only for MNs but also MN molds, are introduced, which allows for the cost-effective production of MNs for drug and vaccine delivery and even diagnostic/monitoring purposes. The focus of this review is to give a brief overview of MN characteristics, material composition, as well as the production and commercial development of MN-based systems.

Citing Articles

Microneedles as Modern Carriers of Plant Extracts.

Chudzinska-Skorupinska J, Wawrzynczak A, Feliczak-Guzik A Micromachines (Basel). 2025; 16(2).

PMID: 40047580 PMC: 11857659. DOI: 10.3390/mi16020143.


Dissolving microneedle patch for transdermal delivery of perindopril erbumine.

Altaf Z, Ahmad Z, Mahmood A, Shchinar S, Latif R Inflammopharmacology. 2025; .

PMID: 40009346 DOI: 10.1007/s10787-025-01696-z.


Beyond the Needle: Innovative Microneedle-Based Transdermal Vaccination.

Nguyen H Medicines (Basel). 2025; 12(1).

PMID: 39982324 PMC: 11843882. DOI: 10.3390/medicines12010004.


Recent advances in iontophoresis-assisted microneedle devices for transdermal biosensing and drug delivery.

Wang G, Moriyama N, Tottori S, Nishizawa M Mater Today Bio. 2025; 31:101504.

PMID: 39906204 PMC: 11791360. DOI: 10.1016/j.mtbio.2025.101504.


Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review.

Hulimane Shivaswamy R, Binulal P, Benoy A, Lakshmiramanan K, Bhaskar N, Pandya H ACS Mater Au. 2025; 5(1):115-140.

PMID: 39802146 PMC: 11718548. DOI: 10.1021/acsmaterialsau.4c00125.


References
1.
Takeuchi K, Takama N, Kim B, Sharma K, Paul O, Ruther P . Microfluidic chip to interface porous microneedles for ISF collection. Biomed Microdevices. 2019; 21(1):28. DOI: 10.1007/s10544-019-0370-4. View

2.
Thomas B, Finnin B . The transdermal revolution. Drug Discov Today. 2004; 9(16):697-703. DOI: 10.1016/S1359-6446(04)03180-0. View

3.
Kim Y, Quan F, Yoo D, Compans R, Kang S, Prausnitz M . Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine. 2009; 27(49):6932-8. PMC: 2913971. DOI: 10.1016/j.vaccine.2009.08.108. View

4.
Li H, Low Y, Chong H, Zin M, Lee C, Li B . Microneedle-Mediated Delivery of Copper Peptide Through Skin. Pharm Res. 2015; 32(8):2678-89. DOI: 10.1007/s11095-015-1652-z. View

5.
Liu Y, Eng P, Guy O, Roberts K, Ashraf H, Knight N . Advanced deep reactive-ion etching technology for hollow microneedles for transdermal blood sampling and drug delivery. IET Nanobiotechnol. 2013; 7(2):59-62. DOI: 10.1049/iet-nbt.2012.0018. View